Original Nerve Growth Factor Mimetic Dipeptide GK-2 Limits the Manifestations of Hemorrhagic Stroke in Rats

The protective effects of a new low-molecular-weight mimetic of nerve growth factor hexamethylene diamide bis-(N-monosuccinyl-L-glutamine-L-lysine; GK-2) were studied on the experimental model of hemorrhagic stroke (intracerebral posttraumatic hematoma) in rats. Intraperitoneal injections of GK-2 in...

Full description

Saved in:
Bibliographic Details
Published in:Bulletin of experimental biology and medicine 2013-03, Vol.154 (5), p.642-644
Main Authors: Kraineva, V. A., Gudasheva, T. A., Kotelnikova, S. O., Antipova, T. A., Seredenin, S. B.
Format: Article
Language:English
Subjects:
Animals
Biomedical and Life Sciences
Biomedicine
Cell Biology
Dipeptides - therapeutic use
Disease Models, Animal
Glutamine
Internal Medicine
Intracranial Hemorrhages - drug therapy
Intracranial Hemorrhages - mortality
Laboratory Medicine
Male
Nerve Growth Factor
Neuroprotective Agents - therapeutic use
Pathology
Pharmacology and Toxicology
Rats
Stroke - drug therapy
Stroke - mortality
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c503t-5783a50a5a139c3df0dde08a634f49454b9442c0a7a55a83b3ee4dc827f59e2e3
cites cdi_FETCH-LOGICAL-c503t-5783a50a5a139c3df0dde08a634f49454b9442c0a7a55a83b3ee4dc827f59e2e3
container_end_page 644
container_issue 5
container_start_page 642
container_title Bulletin of experimental biology and medicine
container_volume 154
creator Kraineva, V. A.
Gudasheva, T. A.
Kotelnikova, S. O.
Antipova, T. A.
Seredenin, S. B.
description The protective effects of a new low-molecular-weight mimetic of nerve growth factor hexamethylene diamide bis-(N-monosuccinyl-L-glutamine-L-lysine; GK-2) were studied on the experimental model of hemorrhagic stroke (intracerebral posttraumatic hematoma) in rats. Intraperitoneal injections of GK-2 in a dose of 1 mg/kg 4 and 24 h after surgery and 24 h before testing the CNS function on days 3, 7, and 14 prevent death of experimental animals, reduce the neurological deficit, and normalized behavior.
doi_str_mv 10.1007/s10517-013-2020-9
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1430862443</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A338038197</galeid><sourcerecordid>A338038197</sourcerecordid><originalsourceid>FETCH-LOGICAL-c503t-5783a50a5a139c3df0dde08a634f49454b9442c0a7a55a83b3ee4dc827f59e2e3</originalsourceid><addsrcrecordid>eNqFkk1v1DAQhi0EokvhB3BBlpBQLym2x944x6rQFrGlEh9ny5tMNm6TeGs7VPx7HLZAi0DIB8szz7yeGb2EPOfskDNWvo6cKV4WjEMhmGBF9YAsuCqh0ELwh2TBMlRIrfUeeRLj5fxkS_6Y7AlYqhyuFuTqIriNG21PP2D4ivQ0-JvU0RNbJx_ouRswuZq-cVvcJtfk_PtC0JUbXIo0dUjP7ehajMkm58dIfUvPcPAhdHaT6z6l4K-QupF-tCk-JY9a20d8dnvvky8nbz8fnxWri9N3x0erolYMUqFKDVYxqyyHqoamZU2DTNslyFZWUsl1JaWomS2tUlbDGhBlU2tRtqpCgbBPDna62-Cvp9ycGVysse_tiH6KhktgeimkhP-joBjPn4LK6Ms_0Es_hby5WZCDZJDB39TG9mjc2PoUbD2LmiMAzUDzqszU4V-ofBocXO1HbF2O3yt4daegQ9unLvp--rH1-yDfgXXwMQZszTa4wYZvhjMzm8bsTGOyacxsGjP3_OJ2smk9YPOr4qdLMiB2QMypcYPhzuj_VP0OQRfIGA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1413403149</pqid></control><display><type>article</type><title>Original Nerve Growth Factor Mimetic Dipeptide GK-2 Limits the Manifestations of Hemorrhagic Stroke in Rats</title><source>Springer Nature</source><creator>Kraineva, V. A. ; Gudasheva, T. A. ; Kotelnikova, S. O. ; Antipova, T. A. ; Seredenin, S. B.</creator><creatorcontrib>Kraineva, V. A. ; Gudasheva, T. A. ; Kotelnikova, S. O. ; Antipova, T. A. ; Seredenin, S. B.</creatorcontrib><description>The protective effects of a new low-molecular-weight mimetic of nerve growth factor hexamethylene diamide bis-(N-monosuccinyl-L-glutamine-L-lysine; GK-2) were studied on the experimental model of hemorrhagic stroke (intracerebral posttraumatic hematoma) in rats. Intraperitoneal injections of GK-2 in a dose of 1 mg/kg 4 and 24 h after surgery and 24 h before testing the CNS function on days 3, 7, and 14 prevent death of experimental animals, reduce the neurological deficit, and normalized behavior.</description><identifier>ISSN: 0007-4888</identifier><identifier>EISSN: 1573-8221</identifier><identifier>DOI: 10.1007/s10517-013-2020-9</identifier><identifier>PMID: 23658889</identifier><identifier>CODEN: BEXBAN</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Animals ; Biomedical and Life Sciences ; Biomedicine ; Cell Biology ; Dipeptides - therapeutic use ; Disease Models, Animal ; Glutamine ; Internal Medicine ; Intracranial Hemorrhages - drug therapy ; Intracranial Hemorrhages - mortality ; Laboratory Medicine ; Male ; Nerve Growth Factor ; Neuroprotective Agents - therapeutic use ; Pathology ; Pharmacology and Toxicology ; Rats ; Stroke - drug therapy ; Stroke - mortality</subject><ispartof>Bulletin of experimental biology and medicine, 2013-03, Vol.154 (5), p.642-644</ispartof><rights>Springer Science+Business Media New York 2013</rights><rights>COPYRIGHT 2013 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c503t-5783a50a5a139c3df0dde08a634f49454b9442c0a7a55a83b3ee4dc827f59e2e3</citedby><cites>FETCH-LOGICAL-c503t-5783a50a5a139c3df0dde08a634f49454b9442c0a7a55a83b3ee4dc827f59e2e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23658889$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kraineva, V. A.</creatorcontrib><creatorcontrib>Gudasheva, T. A.</creatorcontrib><creatorcontrib>Kotelnikova, S. O.</creatorcontrib><creatorcontrib>Antipova, T. A.</creatorcontrib><creatorcontrib>Seredenin, S. B.</creatorcontrib><title>Original Nerve Growth Factor Mimetic Dipeptide GK-2 Limits the Manifestations of Hemorrhagic Stroke in Rats</title><title>Bulletin of experimental biology and medicine</title><addtitle>Bull Exp Biol Med</addtitle><addtitle>Bull Exp Biol Med</addtitle><description>The protective effects of a new low-molecular-weight mimetic of nerve growth factor hexamethylene diamide bis-(N-monosuccinyl-L-glutamine-L-lysine; GK-2) were studied on the experimental model of hemorrhagic stroke (intracerebral posttraumatic hematoma) in rats. Intraperitoneal injections of GK-2 in a dose of 1 mg/kg 4 and 24 h after surgery and 24 h before testing the CNS function on days 3, 7, and 14 prevent death of experimental animals, reduce the neurological deficit, and normalized behavior.</description><subject>Animals</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cell Biology</subject><subject>Dipeptides - therapeutic use</subject><subject>Disease Models, Animal</subject><subject>Glutamine</subject><subject>Internal Medicine</subject><subject>Intracranial Hemorrhages - drug therapy</subject><subject>Intracranial Hemorrhages - mortality</subject><subject>Laboratory Medicine</subject><subject>Male</subject><subject>Nerve Growth Factor</subject><subject>Neuroprotective Agents - therapeutic use</subject><subject>Pathology</subject><subject>Pharmacology and Toxicology</subject><subject>Rats</subject><subject>Stroke - drug therapy</subject><subject>Stroke - mortality</subject><issn>0007-4888</issn><issn>1573-8221</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqFkk1v1DAQhi0EokvhB3BBlpBQLym2x944x6rQFrGlEh9ny5tMNm6TeGs7VPx7HLZAi0DIB8szz7yeGb2EPOfskDNWvo6cKV4WjEMhmGBF9YAsuCqh0ELwh2TBMlRIrfUeeRLj5fxkS_6Y7AlYqhyuFuTqIriNG21PP2D4ivQ0-JvU0RNbJx_ouRswuZq-cVvcJtfk_PtC0JUbXIo0dUjP7ehajMkm58dIfUvPcPAhdHaT6z6l4K-QupF-tCk-JY9a20d8dnvvky8nbz8fnxWri9N3x0erolYMUqFKDVYxqyyHqoamZU2DTNslyFZWUsl1JaWomS2tUlbDGhBlU2tRtqpCgbBPDna62-Cvp9ycGVysse_tiH6KhktgeimkhP-joBjPn4LK6Ms_0Es_hby5WZCDZJDB39TG9mjc2PoUbD2LmiMAzUDzqszU4V-ofBocXO1HbF2O3yt4daegQ9unLvp--rH1-yDfgXXwMQZszTa4wYZvhjMzm8bsTGOyacxsGjP3_OJ2smk9YPOr4qdLMiB2QMypcYPhzuj_VP0OQRfIGA</recordid><startdate>20130301</startdate><enddate>20130301</enddate><creator>Kraineva, V. A.</creator><creator>Gudasheva, T. A.</creator><creator>Kotelnikova, S. O.</creator><creator>Antipova, T. A.</creator><creator>Seredenin, S. B.</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>7TK</scope></search><sort><creationdate>20130301</creationdate><title>Original Nerve Growth Factor Mimetic Dipeptide GK-2 Limits the Manifestations of Hemorrhagic Stroke in Rats</title><author>Kraineva, V. A. ; Gudasheva, T. A. ; Kotelnikova, S. O. ; Antipova, T. A. ; Seredenin, S. B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c503t-5783a50a5a139c3df0dde08a634f49454b9442c0a7a55a83b3ee4dc827f59e2e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Animals</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cell Biology</topic><topic>Dipeptides - therapeutic use</topic><topic>Disease Models, Animal</topic><topic>Glutamine</topic><topic>Internal Medicine</topic><topic>Intracranial Hemorrhages - drug therapy</topic><topic>Intracranial Hemorrhages - mortality</topic><topic>Laboratory Medicine</topic><topic>Male</topic><topic>Nerve Growth Factor</topic><topic>Neuroprotective Agents - therapeutic use</topic><topic>Pathology</topic><topic>Pharmacology and Toxicology</topic><topic>Rats</topic><topic>Stroke - drug therapy</topic><topic>Stroke - mortality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kraineva, V. A.</creatorcontrib><creatorcontrib>Gudasheva, T. A.</creatorcontrib><creatorcontrib>Kotelnikova, S. O.</creatorcontrib><creatorcontrib>Antipova, T. A.</creatorcontrib><creatorcontrib>Seredenin, S. B.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><jtitle>Bulletin of experimental biology and medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kraineva, V. A.</au><au>Gudasheva, T. A.</au><au>Kotelnikova, S. O.</au><au>Antipova, T. A.</au><au>Seredenin, S. B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Original Nerve Growth Factor Mimetic Dipeptide GK-2 Limits the Manifestations of Hemorrhagic Stroke in Rats</atitle><jtitle>Bulletin of experimental biology and medicine</jtitle><stitle>Bull Exp Biol Med</stitle><addtitle>Bull Exp Biol Med</addtitle><date>2013-03-01</date><risdate>2013</risdate><volume>154</volume><issue>5</issue><spage>642</spage><epage>644</epage><pages>642-644</pages><issn>0007-4888</issn><eissn>1573-8221</eissn><coden>BEXBAN</coden><abstract>The protective effects of a new low-molecular-weight mimetic of nerve growth factor hexamethylene diamide bis-(N-monosuccinyl-L-glutamine-L-lysine; GK-2) were studied on the experimental model of hemorrhagic stroke (intracerebral posttraumatic hematoma) in rats. Intraperitoneal injections of GK-2 in a dose of 1 mg/kg 4 and 24 h after surgery and 24 h before testing the CNS function on days 3, 7, and 14 prevent death of experimental animals, reduce the neurological deficit, and normalized behavior.</abstract><cop>Boston</cop><pub>Springer US</pub><pmid>23658889</pmid><doi>10.1007/s10517-013-2020-9</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0007-4888
ispartof Bulletin of experimental biology and medicine, 2013-03, Vol.154 (5), p.642-644
issn 0007-4888
1573-8221
language eng
recordid cdi_proquest_miscellaneous_1430862443
source Springer Nature
subjects Animals
Biomedical and Life Sciences
Biomedicine
Cell Biology
Dipeptides - therapeutic use
Disease Models, Animal
Glutamine
Internal Medicine
Intracranial Hemorrhages - drug therapy
Intracranial Hemorrhages - mortality
Laboratory Medicine
Male
Nerve Growth Factor
Neuroprotective Agents - therapeutic use
Pathology
Pharmacology and Toxicology
Rats
Stroke - drug therapy
Stroke - mortality
title Original Nerve Growth Factor Mimetic Dipeptide GK-2 Limits the Manifestations of Hemorrhagic Stroke in Rats
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T18%3A20%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Original%20Nerve%20Growth%20Factor%20Mimetic%20Dipeptide%20GK-2%20Limits%20the%20Manifestations%20of%20Hemorrhagic%20Stroke%20in%20Rats&rft.jtitle=Bulletin%20of%20experimental%20biology%20and%20medicine&rft.au=Kraineva,%20V.%20A.&rft.date=2013-03-01&rft.volume=154&rft.issue=5&rft.spage=642&rft.epage=644&rft.pages=642-644&rft.issn=0007-4888&rft.eissn=1573-8221&rft.coden=BEXBAN&rft_id=info:doi/10.1007/s10517-013-2020-9&rft_dat=%3Cgale_proqu%3EA338038197%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c503t-5783a50a5a139c3df0dde08a634f49454b9442c0a7a55a83b3ee4dc827f59e2e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1413403149&rft_id=info:pmid/23658889&rft_galeid=A338038197&rfr_iscdi=true